An audit of delays in diagnosis and treatment of lymphoma in district hospitals in the northern region of the United Kingdom
Summary Prompt diagnosis and treatment of malignant disorders is generally regarded as improving outcomes. There is good evidence for this in the most common solid tumours, bronchus, breast and large bowel. It might be expected that delays in diagnosis of lymphoma could affect the outcome of treatme...
Gespeichert in:
| Veröffentlicht in: | Clinical and laboratory haematology 2000-06, Vol.22 (3), p.157-160 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 160 |
|---|---|
| container_issue | 3 |
| container_start_page | 157 |
| container_title | Clinical and laboratory haematology |
| container_volume | 22 |
| creator | Summerfield, G.P. Carey†, P.J. Galloway†, M.J. Tinegate§, H.N. |
| description | Summary
Prompt diagnosis and treatment of malignant disorders is generally regarded as improving outcomes. There is good evidence for this in the most common solid tumours, bronchus, breast and large bowel. It might be expected that delays in diagnosis of lymphoma could affect the outcome of treatment, as well as causing dissatisfaction among patients and relatives. However it would be difficult to obtain definite evidence for this as a randomised trial of delay is an unethical proposition.
The recently introduced National Priorities Guidance (NPG) Cancer Targets require that all new patients with suspected cancer should see a specialist within two weeks of referral by their General Practitioner (GP). There is no good evidence to support this requirement in lymphoma, but we decided to audit delays at different stages of the process of diagnosis and initial treatment of lymphoma as a base line to assess current performance, identify possible shortcomings and set achievable standards amenable to further audit. |
| doi_str_mv | 10.1046/j.1365-2257.2000.00303.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71729688</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71729688</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3833-c4b0c19af8419ccfd24da8e380c2c8ef82284dd48c4407915849e7252f8d87613</originalsourceid><addsrcrecordid>eNpNkU1PGzEQhi1UVFLav4B8qLjt1l-79h56QBEQSkQv0B4tY3sTp7t2ajtqIvXHdzcJ0NOMxs8zluYFAGJUYsTqL6sS07oqCKl4SRBCJUIU0XJ7AiavD-_ABGGGi0ZU7Ax8SGmFEKaY8_fgDKOGYlyzCfh75aHaGJdhaKGxndol6Dw0Ti18SC5B5Q3M0arcW7-Hul2_XoZeHbCUo9MZLkNau6y6vZyXFvoQhxI9jHbhgh_FcfzkXbYG3ju_MKH_CE7bwbGfjvUcPN1cP05nxfz77d30al5oKigtNHtGGjeqFQw3WreGMKOEpQJpooVtBSGCGcOEZgzxBleCNZaTirTCCF5jeg4uD3vXMfze2JRl75K2Xae8DZskOeakqYUYwIsjuHnurZHr6HoVd_LlXgPw-QiopFXXRuW1S28cIzXj44dfD9gf19ndf2vkGJ9cyTElOaYkx_jkPj65lXff5rOhG_zi4A_3tdtXX8VfsuaUV_Lnw62cN9PHGftxIwX9B0HtnUc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71729688</pqid></control><display><type>article</type><title>An audit of delays in diagnosis and treatment of lymphoma in district hospitals in the northern region of the United Kingdom</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Summerfield, G.P. ; Carey†, P.J. ; Galloway†, M.J. ; Tinegate§, H.N.</creator><creatorcontrib>Summerfield, G.P. ; Carey†, P.J. ; Galloway†, M.J. ; Tinegate§, H.N.</creatorcontrib><description>Summary
Prompt diagnosis and treatment of malignant disorders is generally regarded as improving outcomes. There is good evidence for this in the most common solid tumours, bronchus, breast and large bowel. It might be expected that delays in diagnosis of lymphoma could affect the outcome of treatment, as well as causing dissatisfaction among patients and relatives. However it would be difficult to obtain definite evidence for this as a randomised trial of delay is an unethical proposition.
The recently introduced National Priorities Guidance (NPG) Cancer Targets require that all new patients with suspected cancer should see a specialist within two weeks of referral by their General Practitioner (GP). There is no good evidence to support this requirement in lymphoma, but we decided to audit delays at different stages of the process of diagnosis and initial treatment of lymphoma as a base line to assess current performance, identify possible shortcomings and set achievable standards amenable to further audit.</description><identifier>ISSN: 0141-9854</identifier><identifier>EISSN: 1365-2257</identifier><identifier>DOI: 10.1046/j.1365-2257.2000.00303.x</identifier><identifier>PMID: 10931164</identifier><identifier>CODEN: CLHAD3</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Biological and medical sciences ; Diagnostic delay ; district hospitals ; Family Practice - standards ; Guideline Adherence ; Hematologic and hematopoietic diseases ; Hospitals, Public - standards ; Humans ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; lymphoma ; Lymphoma - diagnosis ; Lymphoma - therapy ; Medical Audit ; Medical sciences ; Patient Acceptance of Health Care ; patient delay ; Prognosis ; Referral and Consultation - standards ; Retrospective Studies ; Time Factors ; treatment delay ; Treatment Outcome ; United Kingdom</subject><ispartof>Clinical and laboratory haematology, 2000-06, Vol.22 (3), p.157-160</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3833-c4b0c19af8419ccfd24da8e380c2c8ef82284dd48c4407915849e7252f8d87613</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1365-2257.2000.00303.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1365-2257.2000.00303.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1426471$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10931164$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Summerfield, G.P.</creatorcontrib><creatorcontrib>Carey†, P.J.</creatorcontrib><creatorcontrib>Galloway†, M.J.</creatorcontrib><creatorcontrib>Tinegate§, H.N.</creatorcontrib><title>An audit of delays in diagnosis and treatment of lymphoma in district hospitals in the northern region of the United Kingdom</title><title>Clinical and laboratory haematology</title><addtitle>Clin Lab Haematol</addtitle><description>Summary
Prompt diagnosis and treatment of malignant disorders is generally regarded as improving outcomes. There is good evidence for this in the most common solid tumours, bronchus, breast and large bowel. It might be expected that delays in diagnosis of lymphoma could affect the outcome of treatment, as well as causing dissatisfaction among patients and relatives. However it would be difficult to obtain definite evidence for this as a randomised trial of delay is an unethical proposition.
The recently introduced National Priorities Guidance (NPG) Cancer Targets require that all new patients with suspected cancer should see a specialist within two weeks of referral by their General Practitioner (GP). There is no good evidence to support this requirement in lymphoma, but we decided to audit delays at different stages of the process of diagnosis and initial treatment of lymphoma as a base line to assess current performance, identify possible shortcomings and set achievable standards amenable to further audit.</description><subject>Biological and medical sciences</subject><subject>Diagnostic delay</subject><subject>district hospitals</subject><subject>Family Practice - standards</subject><subject>Guideline Adherence</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hospitals, Public - standards</subject><subject>Humans</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>lymphoma</subject><subject>Lymphoma - diagnosis</subject><subject>Lymphoma - therapy</subject><subject>Medical Audit</subject><subject>Medical sciences</subject><subject>Patient Acceptance of Health Care</subject><subject>patient delay</subject><subject>Prognosis</subject><subject>Referral and Consultation - standards</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><subject>treatment delay</subject><subject>Treatment Outcome</subject><subject>United Kingdom</subject><issn>0141-9854</issn><issn>1365-2257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkU1PGzEQhi1UVFLav4B8qLjt1l-79h56QBEQSkQv0B4tY3sTp7t2ajtqIvXHdzcJ0NOMxs8zluYFAGJUYsTqL6sS07oqCKl4SRBCJUIU0XJ7AiavD-_ABGGGi0ZU7Ax8SGmFEKaY8_fgDKOGYlyzCfh75aHaGJdhaKGxndol6Dw0Ti18SC5B5Q3M0arcW7-Hul2_XoZeHbCUo9MZLkNau6y6vZyXFvoQhxI9jHbhgh_FcfzkXbYG3ju_MKH_CE7bwbGfjvUcPN1cP05nxfz77d30al5oKigtNHtGGjeqFQw3WreGMKOEpQJpooVtBSGCGcOEZgzxBleCNZaTirTCCF5jeg4uD3vXMfze2JRl75K2Xae8DZskOeakqYUYwIsjuHnurZHr6HoVd_LlXgPw-QiopFXXRuW1S28cIzXj44dfD9gf19ndf2vkGJ9cyTElOaYkx_jkPj65lXff5rOhG_zi4A_3tdtXX8VfsuaUV_Lnw62cN9PHGftxIwX9B0HtnUc</recordid><startdate>200006</startdate><enddate>200006</enddate><creator>Summerfield, G.P.</creator><creator>Carey†, P.J.</creator><creator>Galloway†, M.J.</creator><creator>Tinegate§, H.N.</creator><general>Blackwell Science Ltd</general><general>Blackwell Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200006</creationdate><title>An audit of delays in diagnosis and treatment of lymphoma in district hospitals in the northern region of the United Kingdom</title><author>Summerfield, G.P. ; Carey†, P.J. ; Galloway†, M.J. ; Tinegate§, H.N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3833-c4b0c19af8419ccfd24da8e380c2c8ef82284dd48c4407915849e7252f8d87613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Biological and medical sciences</topic><topic>Diagnostic delay</topic><topic>district hospitals</topic><topic>Family Practice - standards</topic><topic>Guideline Adherence</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hospitals, Public - standards</topic><topic>Humans</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>lymphoma</topic><topic>Lymphoma - diagnosis</topic><topic>Lymphoma - therapy</topic><topic>Medical Audit</topic><topic>Medical sciences</topic><topic>Patient Acceptance of Health Care</topic><topic>patient delay</topic><topic>Prognosis</topic><topic>Referral and Consultation - standards</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><topic>treatment delay</topic><topic>Treatment Outcome</topic><topic>United Kingdom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Summerfield, G.P.</creatorcontrib><creatorcontrib>Carey†, P.J.</creatorcontrib><creatorcontrib>Galloway†, M.J.</creatorcontrib><creatorcontrib>Tinegate§, H.N.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and laboratory haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Summerfield, G.P.</au><au>Carey†, P.J.</au><au>Galloway†, M.J.</au><au>Tinegate§, H.N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An audit of delays in diagnosis and treatment of lymphoma in district hospitals in the northern region of the United Kingdom</atitle><jtitle>Clinical and laboratory haematology</jtitle><addtitle>Clin Lab Haematol</addtitle><date>2000-06</date><risdate>2000</risdate><volume>22</volume><issue>3</issue><spage>157</spage><epage>160</epage><pages>157-160</pages><issn>0141-9854</issn><eissn>1365-2257</eissn><coden>CLHAD3</coden><abstract>Summary
Prompt diagnosis and treatment of malignant disorders is generally regarded as improving outcomes. There is good evidence for this in the most common solid tumours, bronchus, breast and large bowel. It might be expected that delays in diagnosis of lymphoma could affect the outcome of treatment, as well as causing dissatisfaction among patients and relatives. However it would be difficult to obtain definite evidence for this as a randomised trial of delay is an unethical proposition.
The recently introduced National Priorities Guidance (NPG) Cancer Targets require that all new patients with suspected cancer should see a specialist within two weeks of referral by their General Practitioner (GP). There is no good evidence to support this requirement in lymphoma, but we decided to audit delays at different stages of the process of diagnosis and initial treatment of lymphoma as a base line to assess current performance, identify possible shortcomings and set achievable standards amenable to further audit.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>10931164</pmid><doi>10.1046/j.1365-2257.2000.00303.x</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0141-9854 |
| ispartof | Clinical and laboratory haematology, 2000-06, Vol.22 (3), p.157-160 |
| issn | 0141-9854 1365-2257 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71729688 |
| source | Wiley Online Library - AutoHoldings Journals; MEDLINE |
| subjects | Biological and medical sciences Diagnostic delay district hospitals Family Practice - standards Guideline Adherence Hematologic and hematopoietic diseases Hospitals, Public - standards Humans Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis lymphoma Lymphoma - diagnosis Lymphoma - therapy Medical Audit Medical sciences Patient Acceptance of Health Care patient delay Prognosis Referral and Consultation - standards Retrospective Studies Time Factors treatment delay Treatment Outcome United Kingdom |
| title | An audit of delays in diagnosis and treatment of lymphoma in district hospitals in the northern region of the United Kingdom |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T21%3A47%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20audit%20of%20delays%20in%20diagnosis%20and%20treatment%20of%20lymphoma%20in%20district%20hospitals%20in%20the%20northern%20region%20of%20the%20United%20Kingdom&rft.jtitle=Clinical%20and%20laboratory%20haematology&rft.au=Summerfield,%20G.P.&rft.date=2000-06&rft.volume=22&rft.issue=3&rft.spage=157&rft.epage=160&rft.pages=157-160&rft.issn=0141-9854&rft.eissn=1365-2257&rft.coden=CLHAD3&rft_id=info:doi/10.1046/j.1365-2257.2000.00303.x&rft_dat=%3Cproquest_pubme%3E71729688%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71729688&rft_id=info:pmid/10931164&rfr_iscdi=true |